본문 바로가기
KERD
논문KCI 등재

렘수면행동장애의 치료와 관리의 최신지견

Recent Update on Treatment and Management of Rapid Eye Movement Sleep Behavior Disorder

신원철|변정익
대한신경과학회 (Korean Neurological Association)|2021.05|대한신경과학회지 (Journal of the Korean Neurological Association)|제39권 제2호|pp. 68-74

1

조회

0

다운로드

1

인용

0

참고문헌

키워드

CounselingMelatoninTherapeuticsREM sleep behavior disorderClonazepam
주제분류신경과학

초록

Rapid eye movement sleep behavior disorder (RBD) is a parasomnia that is characterized by dream-enactment behavior, which can often result in sleep related injury. RBD is strongly associated with neurodegenerative disease especially with alpha-synucleinopathy. More than 70% of the patients convert to neurodegenerative disease including Parkinson’s disease or diffuse Lewy body dementia with a median period of 7.5 years. Treatment for RBD is currently focused on symptomatic treatment to prevent the injury. First step is establishing safe sleep environment to avoid injury. Clonazepam and melatonin are most commonly used medication for symptomatic treatment for RBD, however, well-designed randomized clinical trials are lacking. Prognostic counselling with longitudinal follow-up is also crucial in managing patients with RBD, which should be individualized for each patient with regular systematic follow-up evaluation.

Abstract

Rapid eye movement sleep behavior disorder (RBD) is a parasomnia that is characterized by dream-enactment behavior, which can often result in sleep related injury. RBD is strongly associated with neurodegenerative disease especially with alpha-synucleinopathy. More than 70% of the patients convert to neurodegenerative disease including Parkinson’s disease or diffuse Lewy body dementia with a median period of 7.5 years. Treatment for RBD is currently focused on symptomatic treatment to prevent the injury. First step is establishing safe sleep environment to avoid injury. Clonazepam and melatonin are most commonly used medication for symptomatic treatment for RBD, however, well-designed randomized clinical trials are lacking. Prognostic counselling with longitudinal follow-up is also crucial in managing patients with RBD, which should be individualized for each patient with regular systematic follow-up evaluation.

참고문헌 (45)

  1. Schenck CH, "Chronic behavioral disorders of human REM sleep: a new category of parasomnia", Sleep, 9, pp.293~308 (1986)
  2. AAoS M, "The International Classification of Sleep Disorders – Third Edition (ICSD-3)", American Academy of Sleep Medicine, ~ (2014)
  3. 유수연, "렘수면 행동 장애", Journal of sleep medicine, 15(1), pp.1~7 (2018), 대한수면연구학회[DOI]
  4. Iranzo A, "Severe obstructive sleep apnea", hypopnea mimicking REM sleep behavior disorder, 2005, pp.28, 203~206
  5. McCarter SJ, "Factors associated with injury in REM sleep behavior disorder", Sleep Med, 15, pp.1332~1338 (2014)
  6. Högl B, "Idiopathic REM sleep behaviour disorder and neurodegeneration - an update", Nat Rev Neurol, 14, pp.40~55 (2018)
  7. Postuma RB, "Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study", Brain, 142, pp.744~759 (2019)
  8. McCarter SJ, "Treatment outcomes in REM sleep behavior disorder", Sleep Med, 14, pp.237~242 (2013)
  9. Devnani P, "Management of REM sleep behavior disorder:an evidence based review", Ann Indian Acad Neurol, 18, pp.1~5 (2015)
  10. Howell MJ, "Rapid eye movement sleep behavior disorder and neurodegenerative disease", JAMA Neurol, 72, pp.707~712 (2015)
  11. Gaig C, "Periodic limb movements during sleep mimicking REM sleep behavior disorder: a new form of periodic limb movement disorder", Sleep, 40, pp.zsw063~ (2017)
  12. Dauvilliers Y, "Rapid eye movement sleep behavior disorder and rapid eye movement sleep without atonia in narcolepsy", Sleep Med, 14, pp.775~781 (2013)
  13. Postuma RB, "Antidepressants and REM sleep behavior disorder: isolated side effect or neurodegenerative signal?", Sleep, 36, pp.1579~1585 (2013)
  14. Gilat M, "A critical review of the pharmacological treatment of REM sleep behavior disorder in adults: time for more and larger randomized placebo-controlled trials", J Neurol (2021)
  15. 문혜진, "렘수면행동장애의 치료", Journal of sleep medicine, 6(1), pp.24~28 (2009), 대한수면연구학회
  16. Jung Y, "Treatment of REM sleep behavior disorder", Curr Treat Options Neurol, 18, pp.50~ (2016)
  17. Lapierre O, "Polysomnographic features of REM sleep behavior disorder: development of a scoring method", Neurology, 42, pp.1371~1374 (1992)
  18. Ferri R, "Effects of long-term use of clonazepam on nonrapid eye movement sleep patterns in rapid eye movement sleep behavior disorder", Sleep Med, 14, pp.399~406 (2013)
  19. Lee HJ, "Age of diagnosis and comorbid PLMD predict poor response of REM behavior disorder to clonazepam", J Geriatr Psychiatry Neurol, 34, pp.142~149 (2021)
  20. Li SX, "A prospective, naturalistic follow-up study of treatment outcomes with clonazepam in rapid eye movement sleep behavior disorder", Sleep Med, 21, pp.114~120 (2016)
  21. Shin C, "Clonazepam for probable REM sleep behavior disorder in Parkinson's disease: a randomized placebo-controlled trial", J Neurol Sci, 401, pp.81~86 (2019)
  22. Kunz D, "Melatonin effects in a patient with severe REM sleep behavior disorder: case report and theoretical considerations", Neuropsychobiology, 36, pp.211~214 (1997)
  23. Boeve BF, "Melatonin for treatment of REM sleep behavior disorder in neurologic disorders: results in 14 patients", Sleep Med, 4, pp.281~284 (2003)
  24. Attenburrow ME, "Low dose melatonin improves sleep in healthy middle-aged subjects", Psychopharmacology (Berl), 126, pp.179~181 (1996)
  25. Kunz D, "Melatonin in rapid eye movement sleep behavior disorder:why does it work?", Sleep Med, 14, pp.705~706 (2013)
  26. Brooks PL, "Impaired GABA and glycine transmission triggers cardinal features of rapid eye movement sleep behavior disorder in mice", J Neurosci, 31, pp.7111~7121 (2011)
  27. Gilat M, "Melatonin for rapid eye movement sleep behavior disorder in Parkinson's disease: a randomised controlled trial", Mov Disord, 35, pp.344~349 (2020)
  28. Jun JS, "Prolonged-release melatonin in patients with idiopathic REM sleep behavior disorder", Ann Clin Transl Neurol, 6, pp.716~722 (2019)
  29. Esaki Y, "An open-labeled trial of ramelteon in idiopathic rapid eye movement sleep behavior disorder", J Clin Sleep Med, 12, pp.689~693 (2016)
  30. Sasai T, "Factors associated with the effect of pramipexole on symptoms of idiopathic REM sleep behavior disorder", Parkinsonism Relat Disord, 19, pp.153~157 (2013)
  31. Tan SM, "Pramipexole in the treatment of REM sleep behaviour disorder: a critical review", Psychiatry Research, 243, pp.365~372 (2016)
  32. Di Giacopo R, "Rivastigmine as alternative treatment for refractory REM behavior disorder in Parkinson's disease", Mov Disord, 27, pp.559~561 (2012)
  33. Brunetti V, "Rivastigmine for refractory REM behavior disorder in mild cognitive impairment", Curr Alzheimer Res, 11, pp.267~273 (2014)
  34. Matar E, "Current concepts and controversies in the management of REM sleep behavior disorder", Neurotherapeutics (2021)
  35. Iranzo A, "Neurodegenerative disease status and post-mortem pathology in idiopathic rapid-eye-movement sleep behaviour disorder: an observational cohort study", Lancet Neurol, 12, pp.443~453 (2013)
  36. Iranzo A, "Neurodegenerative disorder risk in idiopathic REM sleep behavior disorder: study in 174 patients", PLoS One, 9, pp.e89741~ (2014)
  37. Stang CD, "Timeline of rapid eye movement sleep behavior disorder in overt alpha-synucleinopathies", Ann Neurol, 89, pp.293~303 (2021)
  38. Teigen LN, "Specialist approaches to prognostic counseling in isolated REM sleep behavior disorder", Sleep Medicine, 79, pp.107~112 (2021)
  39. Videnovic CHSH, "Rapid-eye-movement sleep behavior disorder" (2019), Springer
  40. Junying Zhou, "Clinical Biomarkers of Neurodegeneration in REM Sleep Behavior Disorder", Journal of sleep medicine, 12(2), pp.27~33 (2015), 대한수면연구학회
  41. Iranzo A, "Characteristics of idiopathic REM sleep behavior disorder and that associated with MSA and PD", Neurology, 65, pp.247~252 (2005)
  42. Ferri R, "An observational clinical and video-polysomnographic study of the effects of clonazepam in REM sleep behavior disorder", Sleep Med, 14, pp.24~29 (2013)
  43. Kunz D, "A two-part, double-blind, placebo-controlled trial of exogenous melatonin in REM sleep behaviour disorder", J Sleep Res, 19, pp.591~596 (2010)
  44. Takeuchi N, "Melatonin therapy for REM sleep behavior disorder", Psychiatry Clin Neurosci, 55, pp.267~269 (2001)
  45. Kunz D, "Melatonin as a therapy in REM sleep behavior disorder patients: an open-labeled pilot study on the possible influence of melatonin on REM-sleep regulation", Mov Disord, 14, pp.507~511 (1999)

관련 논문AI추천

렘수면행동장애의 진단과 치료이유진, 조성진대한노인정신의학회 · 노인정신의학2010 · 제14권 제2호렘수면 행동 장애유수연, 전수명, 조용원대한수면연구학회 · Journal of sleep medicine2018 · 제15권 제1호렘수면행동장애 전구상태: 임상적 의의 및 향후 연구 방향윤창호, 이우진대한수면연구학회 · Journal of sleep medicine2024 · 제21권 제1호렘수면 행동 장애와 퇴행성 신경계 질환천상명대한수면연구학회 · Journal of sleep medicine2009 · 제6권 제1호렘수면행동장애의 치료남현우, 문혜진대한수면연구학회 · Journal of sleep medicine2009 · 제6권 제1호렘수면 행동장애 유사 수면장애에 대한 고찰배희원, 송지혜, 이은영, 최하연대한수면의학회 · 수면정신생리2022 · 제29권 제2호

이 간행물의 다른 논문 (15건)

자율신경질환의 척도조은빈, 박기종pp. 60-76자율신경검사의 해석박기홍, 손은희pp. 61-67진단되지 않은 근육병 환자를 대상으로 시행한 늦은 발병 폼페병의 다기관 표적집단선별검사남태승, 김대성, 김병준, 김광국, 박영은, 이정환, 석진명, 박진성, 김숙자, 최영철, 성정준, 신진홍pp. 75-81아산화질소 남용 후에 발생한 아급성연합변성 및 운동신경병석정임, 배진성, 이제완pp. 82-84병리 및 유전자 분석으로 진단된 무증상 뒤센느근디스트로피 보인자: 임상 표현형 범위 확대조민섭, 이종목pp. 85-88
원문 보기